JIHAN HUGGINS: Open Payments
NPI 1467763474 · INDIANAPOLIS, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$605 in 29 payments from 13 companies in 2025. Trend: 2023 $726 · 2024 $809 · 2025 $605
Food & beverage: $605
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $237 |
| Astellas Pharma US Inc | 5 | $109 |
| ABBVIE INC. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 3 | $42 |
| Otsuka America Pharmaceutical, Inc. | 2 | $32 |
| Amgen Inc. | 1 | $19 |
| PFIZER INC. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| GlaxoSmithKline, LLC. | 1 | $16 |
Products named: Wegovy, Veozah, Ozempic, QULIPTA, REXULTI, EVENITY, VYNDAMAX, Auvelity.
Industry payments across IN — which companies pay providers there.
